HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Alternative Surgical Policy for Central Liver Tumors
- Status
- COMPLETED
- Phase
- N/A
Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
- Status
- TERMINATED
- Phase
- PHASE1
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
- Status
- COMPLETED
- Phase
- NA
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis
- Status
- UNKNOWN
- Phase
- NA
RAD001 in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion
- Status
- UNKNOWN
- Phase
- PHASE3